改用不含氯氟烃的定量吸入器。
The change to non-CFC metered dose inhalers.
作者信息
Rubinfeld A
机构信息
Royal Melbourne Hospital, Parkville.
出版信息
Aust Fam Physician. 1997 Dec;26(12):1412-4.
PMID:9470296
Abstract
The first non-chlorofluorocarbon containing (non-CFC) metered dose inhaler (MDI) (i.e. albuterol, Airomir, 3M) has been approved for marketing in over 35 countries. It is hoped by the year 2000 most MDIs will use non-CFC propellants. By the year 2005 it is likely that CFC containing MDIs will no longer be available in developed countries. This article looks at the basis for this change and how it may affect medical practice.
摘要
首款不含氯氟烃的定量吸入器（MDI）（即沙丁胺醇，Airomir，3M公司生产）已在超过35个国家获批上市。人们希望到2000年，大多数定量吸入器将使用非氯氟烃推进剂。到2005年，发达国家可能将不再有含氯氟烃的定量吸入器。本文探讨了这一变化的依据以及它可能对医疗实践产生的影响。
相似文献
1
The change to non-CFC metered dose inhalers.改用不含氯氟烃的定量吸入器。
Aust Fam Physician. 1997 Dec;26(12):1412-4.
2
Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.在接受哮喘药物治疗的患者中，使用氢氟烷烃推进剂递送系统来吸入沙丁胺醇。
Clin Ther. 2000 Feb;22(2):237-47. doi: 10.1016/S0149-2918(00)88482-9.
3
4
Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.将哮喘患者从使用氯氟烃（CFC）沙丁胺醇转换为使用氢氟烷烃-134a（HFA）沙丁胺醇。
J Asthma. 1999;36(1):107-14. doi: 10.3109/02770909909065154.
5
6
Safety of long-term treatment with HFA albuterol.HFA 沙丁胺醇长期治疗的安全性。
Chest. 1999 Apr;115(4):945-51. doi: 10.1378/chest.115.4.945.
7
8
FDA approves new inhaler without CFCs.美国食品药品监督管理局批准了不含氟氯化碳的新型吸入器。
FDA Consum. 2001 Jul-Aug;35(4):3.
9
Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system.随着无氯氟烃药物递送系统的发展，定量吸入器技术取得了进步。
J Aerosol Med. 1999 Fall;12(3):151-60. doi: 10.1089/jam.1999.12.151.
10
Switching to CFC-free beclometasone for asthma.改用不含氯氟烃的倍氯米松治疗哮喘。
Drug Ther Bull. 2008 Jun;46(6):46-8. doi: 10.1136/dtb.2008.05.0013.
Zotero 插件